(Press-News.org) Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by the activity of key cells and signaling pathways, a new study shows.
Led by researchers at NYU Grossman School of Medicine, the study mapped hidden features of inflammation and how they compared in cases of increasing severity of psoriatic disease. The team’s findings may help explain how small areas of skin inflammation can have wide-ranging effects in other parts of the body. Up to one-fifth of those with the skin disease, the researchers note, go on to develop inflammation in the joints, or psoriatic arthritis. The study results, they say, may also offer clues as to why psoriasis can trigger this and other conditions, such as type 2 diabetes, heart disease, and inflammatory bowel disease.
Publishing in the journal Science Immunology online June 2, the new analyses revealed that the location of clusters of cells called fibroblasts, key regulators of inflammation, along with macrophages, a type of white blood cell, varied and were more common in upper layers of the skin in more severe cases of psoriasis.
Further, the research team found that in skin samples from patients with moderate-to-severe psoriatic disease, gene activity increased in more than three dozen molecular pathways tied to metabolism and control of lipid levels, factors known to go awry in diabetes and cardiovascular diseases. This increased gene activity even occurred in clear skin far away from any lesions.
“Our initial goal was to find measurable molecular signals that could tell us who is more likely to develop severe psoriasis, as well as who is at higher risk of developing related disorders that often accompany psoriasis, such as arthritis and cardiovascular disease,” said study co-senior investigator Jose Scher, MD.
“Having found signals with potential systemic consequences, we are now working to understand how skin inflammation can lead to widespread disease affecting other organs,” said Scher, the Steere Abramson Associate Professor of Medicine in the Department of Medicine at NYU Langone Health, where he also serves as director of its Psoriatic Arthritis Center, and the Judith and Stewart Colton Center for Autoimmunity.
“Our study serves as a valuable resource for the scientific community, offering the most comprehensive archive of cellular and molecular features involved in both diseased and healthy skin,” added study co-senior investigator Shruti Naik, PhD. Naik is an assistant professor in the departments of Pathology, Medicine, and the Ronald O. Perelman Department of Dermatology at NYU Langone.
More than 8 million Americans, and 125 million people worldwide, are estimated to have psoriatic disease. The condition affects men and women equally.
Scher notes that the new study was designed to go beyond current diagnostic tools that focus heavily on visible signs of skin lesions instead of looking at their invisible systemic and molecular effects. While many available therapies, including steroids and immunosuppressive drugs, reduce inflammation and symptoms, they do not address the underlying causes of the disease.
The new study relied on spatial transcriptomics, a technique that carefully charts the molecular and cellular interactions occurring in a specific tissue. Researchers analyzed intact skin samples from 11 men and women with mild to severe cases of psoriatic disease, plus three healthy adults without psoriasis. Spatial transcriptomics, they say, is more powerful than other commonly used techniques that track single cells because it creates a broad image-based map of.where cells are located in tissues and what other cells with which they are communicating.
Naik says the team next plans to use their latest analysis to identify the biological mechanisms involved in skin inflammation in one area and how it affects skin or other organs in another part of the body. Further research is also planned in larger groups of patients and in lesioned and nonlesioned skin from the same patients to determine how disease clears on its own in some and why patients respond differently to the same anti-inflammatory medications.
For the benefit of researchers worldwide, study co-lead investigator and bioinformatician Ikjot Sidhu has archived its spatial transcriptomics analysis online at https://zenodo.org/record/7813973 and https://zenodo/org/record/7562864 .
Funding support for the study was provided by National Institutes of Health grants P30CA016087, T32AR069515, UL1TR001445, DP2AR079173, R01AI168462, and UC2AR081029. Additional funding was provided by the National Psoriasis Foundation, the NYU Colton Center for Autoimmunity, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, the Beatrice Snyder Foundation, The Riley Family Foundation, and the Rheumatology Research Foundation, as well as the NY Stem Cell Foundation.
Naik serves on the advisory boards of Seed Inc. and as a consultant for BiomX. She also receives research funding from Takeda Pharmaceuticals. Scher has served as a consultant for Janssen, Abbvie, Novartis, Pfizer, Sanofi, UCB, and BMS. He also receives research funding from Janssen and Pfizer. Study co-investigator Andrea Neiman, MD, serves as a consultant for Janssen, UCB, AbbView, and BMS. Study co-investigator John Carucci, MD, PhD, also receives research funding from Regeneron, Sanofi, and Genentech.
All of these arrangements are being managed in accordance with the policies and practices of NYU Langone Health.
Besides Naik, Scher, Neimann, Carucci, and Sidhu, other NYU Langone researchers involved in the study are study co-lead investigator Rochelle Castillo, and study co-investigators Igor Dolgalev, Aleksandr Prystupa, Ipsita Subudhi, Di Yan, Piotre Konieczny, Brandon Hsieh, Rebecca Haberman, Shanmugapriya Selvaraj, Tomoe Shiomi, Rhina Medina, Parvathy Vasudevanpillaj Girija, Adriana Heguy, Cynthia Loomis, Luis Chiribogo, and Shane Meehan. Other study co-investigators are Tinyi Chu, at Memorial Sloan Kettering Cancer Center in New York City; Christopher Ritchlin and Maria de la Cruz Garcia-Hernandez, at the University of Rochester in NY; and Johann Gudjonsson, at the University of Michigan in Ann Arbor.
STUDY LINK TO GO LIVE AFTER EMBARGO LIFTS
www.science.org/doi/10.1126/sciimmunol.abq7991
DOI: 10.1126/sciimmunol.abq7991
Media Inquiries:
Shira Polan (from May 30 to June 2)
212-404-4279
shira.polan@nyulangone.org
David March (from June 5)
212-404-3528
david.march@nyulangone.org
END
Study helps explain what drives psoriasis severity and offers clues as to how disease may spread to other body parts
2023-06-02
ELSE PRESS RELEASES FROM THIS DATE:
New study finds strengthening protection of existing parks is crucial for biodiversity conservation
2023-06-02
-With pictures-
In a new study, bioscientists argue that strengthening the protection given to areas already protected under law or by local communities is as critical for safeguarding biodiversity as creating new protected areas.
The research team, which included scientists from Durham University, National University of Singapore (NUS) and Princeton University, found that about 70 per cent of the roughly 5000 species analysed either have no apparent representation in protected areas, occur in protected areas that have been downgraded, downsized or degazetted, ...
Scientists reveal new details of cellular process which prevents spread of cancer
2023-06-02
Researchers have for the first time characterised a unique molecular mechanism of the early stages of programmed cell death or apoptosis, a process which plays a crucial role in prevention of cancer.
The study, which is published today (Friday 2nd June 2023) in Science Advances, was led by Dr Luke Clifton at the STFC ISIS Neutron and Muon Source (ISIS) in Oxfordshire, alongside co-lead Professor Gerhard Gröbner at the University of Umeå and partners at the European Spallation Source in Sweden. It is ...
Development of an AI-based mass spectrometric technique capable of determining the monomeric sequence of a polymer
2023-06-02
1. The National Institute for Materials Science (NIMS) has developed an AI-based mass spectrometric technique capable of determining the monomeric sequence of a polymer. This technique may be useful in gaining a deeper understanding of basic polymeric structures, facilitating the development of new materials and helping solve plastic recycling problems.
2. A polymer is a very large molecule composed of a chain of many (ranging from hundreds to hundreds of thousands) small molecules called monomers that are bonded together. Many common polymers (e.g., plastics and resins) are copolymers, consisting of several different types of monomers. During the copolymerization process, the monomers ...
Non-invasive treatment of uterine fibroids research project secures grant at Baton Rouge Health-Tech Catalyst Pitch Night
2023-06-02
BATON ROUGE – A collaboration among Dr. Frank Greenway of Pennington Biomedical Research Center, Dr. Beverly Ogden of Woman’s Hospital in partnership with LSU, and the University of Louisiana at Lafayette, was named as one of three award recipients at the Baton Rouge Health-Tech Catalyst Pitch Night. The team will investigate non-invasive treatment of uterine fibroids, or benign growths, such as leiomyomas or myomas, that development from the muscle tissue of the uterus.
“Fibroids are non-cancerous tumors in the wall of the uterus that are common, and can cause bleeding, pain, and infertility,” ...
nTIDE May 2023 Jobs Report: Job numbers rebound bringing people with disabilities close to previous high in employment
2023-06-02
East Hanover, NJ – June 2, 2023 – In a sharp reversal, employment indicators rebounded for people with disabilities in May, according to today’s National Trends in Disability Employment – semi-monthly update (nTIDE), issued by Kessler Foundation and the University of New Hampshire’s Institute on Disability (UNH-IOD). Employment appears to be remaining strong despite the threats to the labor market posed by the debt ceiling crisis and ongoing efforts to control inflation.
Month-to-Month nTIDE Numbers (comparing April 2023 to May 2023)
Based ...
American Tinnitus Association elects Wayne State researcher as new chair
2023-06-02
DETROIT – The American Tinnitus Association (ATA) has elected Jinsheng Zhang, Ph.D., professor and chair of the Department of Communication Sciences and Disorders in Wayne State University’s College of Liberal Arts and Sciences, as the new chair of its board of directors. With decades of experience in tinnitus research and work with the ATA, Zhang aims to assist with proactive recruitment of scientists to the field of tinnitus and engage more researchers in ATA grant opportunities that will spur progress toward more effective treatments and cures.
Tinnitus ...
Media Alert: American College of Cardiology to host Sports Cardiology Conference
2023-06-02
The American College of Cardiology will host the annual Care of the Athletic Heart course on June 8-10, 2023, in Washington, including poster abstracts and educational sessions. The course is designed for all clinicians who provide cardiovascular care for the professional, occupational, tactical or recreational athlete. As the athletic population expands to all demographic groups, it is critical that there is a larger contingent of clinicians who understand the latest care and practice management for athletes at every level.
Dermot Phelan, BAO, MBBCh, PhD, FACC, and Megan Wasfy, ...
Immunotherapy for brain cancer metastases shows clinical benefit
2023-06-02
In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving longer than two years. The authors caution that these benefits must be weighed against risk of toxicity, but, overall, the study shows promising results that warrant larger studies and efforts to identify patients most likely to benefit from this treatment. Their findings are published in Nature Medicine and presented simultaneously at the 2023 ASCO Annual Meeting on June 2.
“There ...
Commentary calls for equal access to healthcare for DACA recipients and all immigrants
2023-06-02
The paper, published April 17 in The Lancet Regional Health – Americas, was co-authored by Dr. Gunisha Kaur, an associate professor of anesthesiology at Weill Cornell Medicine and medical director of the Weill Cornell Center for Human Rights; Stephen Yale-Loehr, a professor of immigration law practice at Cornell Law School; and Jin K. Park, a medical student at the Harvard School of Medicine and the first DACA recipient awarded a Rhodes Scholarship.
“The erratic enforcement of the DACA program since its inception has led many immigrants and their families to disengage completely from the healthcare system to avoid risking deportation,” said ...
Taming a frenzied immune system
2023-06-02
Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients. A separate $306,000 NIH Small Business Innovation Research grant supports early testing of a compound developed at UofL as a potential treatment.
The three grants combined total $6.1 million.
During the pandemic, health care providers worked tirelessly to treat patients ...